Advertisement

Autoimmunity and Chagas’ Disease

  • G. B. Takle
  • L. Hudson
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 145)

Abstract

The protozoan flagellate Trypanosoma cruzi is the causative agent of Chagas’ disease and has been estimated to infect between 10 and 12 million people in Central and South America (WHO 1960). T. cruzi has a complex life cycle involving stages in both a vertebrate and an insect vector host, the reduviid or assassin bugs, members of the subfamily Triatominae. Transmission of infective metacyclic trypomastigotes to the vertebrate host occurs following feeding and defecation by the bug and contamination of a wound site or penetration of nearby mucous membranes by the parasite. T. cruzi is thus placed in the class Stercoraria in contrast to the pathogenic African trypanosome species, which are Salivaria, whose transmission to the vertebrate occurs by inoculation via the insect’s salivary glands.

Keywords

Trypanosoma Cruzi Parasite Antigen Carbohydrate Epitope Idiotype Network Fibronectin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrahamson I A, Kloetzel JK (1980) Presence of Trypanosoma cruzi antigen on the surface of both infected and uninfected cells in tissue culture. Parasitology 80: 147–154CrossRefGoogle Scholar
  2. Ada GL, Rose NR (1988) The initiation and early development of autoimmune diseases. Clin Immunol Immunopathol 41:3–9CrossRefGoogle Scholar
  3. Alcina, A., Urzainqui, A. and Carrasco, L. (1988). The heat shock response in Trypanosoma cruzi. Eur. J. Biochem. 172: 121–127PubMedCrossRefGoogle Scholar
  4. Andrade ZA (1983). Mechanisms of myocardial damage in Trypanosoma cruzi infection. Ciba Found Symp 99: 214–233PubMedGoogle Scholar
  5. Andrade ZA, Andrade SG, Oliveira GB, Alonson DR (1978). Hisopathology of the conducting tissue of the heart in Chagas’ myocarditis. Am Heart J 95 (3): 316–324PubMedCrossRefGoogle Scholar
  6. Andrews IW, Katzin AM & Colli W, (1984) Mapping of surface glycoproteins of Trypanosoma cruzi by two dimensional electrophoresis. Eur J Biochem 140: 599–604PubMedCrossRefGoogle Scholar
  7. Anselmi A and Moleiro F (1974) Pathogenic mechanisms in Chagas’ cardiomyopathy. Ciba Found Symp 20: 125–136Google Scholar
  8. Araujo FG (1985). Trypanosoma cruzi: expression of antigens on the membrane surface of parasitized cells. J Immunol 135: 4149–4154PubMedGoogle Scholar
  9. Avila JL, Rojas M and Rieber M (1984). Antibodies to laminin in American cutaneous leishmaniasis. Infect Immun 43: 402–406PubMedGoogle Scholar
  10. Avila JL, Rojas M, Velazquez-Avila G and Rieber M (1987). Antibodies to laminin in Trypanosomarangeli infected subjects. Parasitol. Res. 73: 178–179PubMedCrossRefGoogle Scholar
  11. Barlow DP, Green NM, Kurkinen M and Hogan BLM (1984). Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha helix. EMBO J 3: 2355–2362PubMedGoogle Scholar
  12. Barousse AP, Costa JA, Epasto, La Plume H and Segura EL (1980). Enfermedad de Chagas e immunosupresion. Medicina (Buenos Aires) 40: 17–26Google Scholar
  13. Beard CA, Wrightsman RA and Manning JE (1985). Identification of monoclonal antibodies against the trypomastigote stage of Trypanosoma cruzi by use of iminobiotinylated surface polypeptides. Mol Biochem Parasitol 16: 199–212PubMedCrossRefGoogle Scholar
  14. Beard CA, Wrightsman RA and Manning JE (1988) Stage and strain specific expression of the tandemly repeated 90 kDa surface antigen gene family in Trypanosoma cruzi Mol Biochem Parasitol 28:227–234PubMedCrossRefGoogle Scholar
  15. Ben Nun A, Weckerle H and Cohen IR (1981) Vaccination against autoimmune encephalomyelitis with T-lymphocyte line reactive cells reactive against myelin basic protein. Nature 242: 60–61CrossRefGoogle Scholar
  16. Borst P and Cross GAM (1982) The molecular basis for trypanosome antigenic variation. Cell 29: 291–303PubMedCrossRefGoogle Scholar
  17. Boyer MH, Hoff R, Kipnis TL, Murphy ED & Roths JB (1983)Trypanosoma cruzi: susceptibility in mice carrying mutant gene lpr (lymphoproliferation). Parasite Immunol 5: 135–142PubMedCrossRefGoogle Scholar
  18. Brener Z (1980) Immunity toTrypanosoma cruzi Adv Parasitol 18: 247–275PubMedCrossRefGoogle Scholar
  19. Bretana A and O’Daly JA (1976) Uptake of fetal proteins by Trypanosoma cruzi immunofluorescence and ultrastructural studies. Int Parasitol 6: 379–386CrossRefGoogle Scholar
  20. Bretana A, Avila JH, Arias-Flores M, Contreras M and Tapia FJ (1986) Trypanosoma cruzi and Leishmania spp: immunocytochemical localisation of a laminin-like protein in the plasma membrane. Exp Parasitol 61: 168–175CrossRefGoogle Scholar
  21. Cossio PM, Diez C, Szarfman A, Kreutzer E, Candiolo B and Arana RM (1974a) Chagasic cardiomyopathy: demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 49: 13 025Google Scholar
  22. Cossio PM, Laguens RP, Kreutzer E, Diez C, Segal A and Arana RM (1974b) Chagasic cardiopathy: antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation 50: 1252–1263PubMedGoogle Scholar
  23. Dragon EA, Roberts S, Kato EA and Gabe JD (1987) The genome of Trypanosoma cruzi contains a constitutively expressed tandemly arranged multicopy gene homologous to a major heat shock protein. Mol Cell Biol 7: 1271–1275PubMedGoogle Scholar
  24. Ferguson MAJ, Allen AK and Snary D (1983) Studies on the structure of a phosphoglycoprotein from the parasitic protozoan Trypanosoma cruzi Biochem J 207: 171–174Google Scholar
  25. Ferreira E, Neva F, Gusmao R, Ward F, Rezende J, Rossi A, Amos DB and Johnson AH (1979) HLA and Chagas’ disease. Abs Congresso Internacional Sobre Doenca DeChagas, Rio de Janeiro, Brasil, p 181Google Scholar
  26. Guhl F, Hudson L, Marinkelle CJ, Jaramillo CA and Bridge D (1987) ClinicalTrypanosoma rangeli infection as a complication of Chagas’ disease. Parasitology 94: 475–484PubMedCrossRefGoogle Scholar
  27. Hanson WL (1977) Immune response and mechanisms of resistance in Trypanosoma cruzi In: Chagas’ disease. Pan American Health Organization, scientific publication no 343. PAHO, Washington DC p 22Google Scholar
  28. Hudson L and Hindmarsh PJ (1985) The relationship between autoimmunity and Chagas’ disease: causal or coincidental? Curr Top Microbiol Immunol 117: 167–177PubMedCrossRefGoogle Scholar
  29. Ibanez CF, Affranchino JL and Frasch ACC (1987) Antigenic determinants ofTrypanosoma cruzi defined by cloning of parasite DNA. Mol Biochem ParasitoJ 25: 175–184CrossRefGoogle Scholar
  30. Katzin AM and Colli W (1983) Lectin receptors in Trypanosoma cruzi: an N-acetyl-D-glucosamine containing surface glycoprotein specific for the trypomastigote stage. Biochim Biophys Acta 727: 403–411PubMedCrossRefGoogle Scholar
  31. Khoury EL, Ritacco V, Cossio PM, Laguens RP, Szarfman A, Diez C and Arana RM (1979) Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas’ disease). Clin Exp Immunol 36: 8–15PubMedGoogle Scholar
  32. Koberle F (1974) Pathogenesis of Chagas’ disease. Ciba Found Symp 20: 136–158Google Scholar
  33. Krettli AV and Brener Z (1982) Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. J Immunol 128: 2009–2012PubMedGoogle Scholar
  34. Laguens RP, Meckert PC, Chambo JG (1988) Antiheart antibody-dependent cytotoxicity in the sera of mice chronically infected with Trypanosoma cruzi Infect Immun 56: 993–997PubMedGoogle Scholar
  35. Maeckelt GA (1970) Seroepidemiology of Chagas’ disease. J Parasitol 56: 557–563Google Scholar
  36. Maignon R, Gerke R, Rodriguez M, Urbina J, Hoenicka J, Neury S, Aguirre T, Nehlin J, Knapp T and Crampton J (1988) The tubulin genes of Trypanosoma cruzi Eur J Biochem 171: 285–291CrossRefGoogle Scholar
  37. Martins MS, Hudson L, Krettli AV, Cancado JR and Brener Z (1985) Human and mouse serarecognise the same polypeptide associated with immunological resistance to Trypanosoma cruzi infection. Clin Exp Immunol 61/7: 343–350PubMedGoogle Scholar
  38. McDaniel JP, Howard RJ and Dvorak JA (1986) Identification and analysis of epimastigote surface and metabolic proteins in Trypanosoma cruzi Mol Biochem Parasitol 19: 183–194PubMedCrossRefGoogle Scholar
  39. Miles MA, Cedillos RA, Povoa MM, de Souza AA, Prata A and Macedo V (1981) Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas’ disease? Lancet i: 1338CrossRefGoogle Scholar
  40. Nickell SP, Hoff R and Boyer MH (1985) Susceptibility to acute Trypanosoma cruzi infection in autoimmune strains of mice. Parasite Immunol 7: 377–386PubMedCrossRefGoogle Scholar
  41. Nogueira N (1986) American Trypanosomiasis: Antigens and Host-Parasite Interactions. In, Receptors and Ligands in Intercellular Communication, Vol. 7. Parasite Antigens: Towards New Strategies for Vaccines. T. W. Pearson (ed) 4 pp 91–110. Marcel Dekker Inc. New York. BaselGoogle Scholar
  42. Nogueira N, Chaplan S, Tydings JD, Unkless J and Cohn Z (1981)Trypanosoma cruzi surface antigens of blood and culture forms. J Exp Med 153: 629–639CrossRefGoogle Scholar
  43. Ouaissi MA, Cornette J and Capron A (1986 a) Identification and isolation of Trypanosoma cruzi trypomastigote cell surface protein with properties expected of a fibronectin receptor. Mol Biochem Parasitol 19:201–211PubMedCrossRefGoogle Scholar
  44. Ouaissi MA, Cornette J, Afchain D, Capron A, Gras-Masse H and Tartar A (1986 b) Trypanosoma cruzi infection inhibited by peptides modelled from a fibronectin cell attachment domain. Science 234: 603–607PubMedCrossRefGoogle Scholar
  45. Peterson DS, Wrightsman RA and Manning JE (1986) Cloning of a major surface antigen gene of Trypanosoma cruzi and identification of a nona peptide repeat. Nature 322: 566–568PubMedCrossRefGoogle Scholar
  46. Peyrol S, Ouaissi MA, Capron A and Grimaud J A (1987) Trypanosoma cruzi: ultrastructural visualisation of fibronectin bound to culture forms. Exp Parasitol 63: 112–144PubMedCrossRefGoogle Scholar
  47. Prioli RP, Rosenberg I, Shivakumar S, Pereira MEA (1988) Specific binding of human plasma high density lipoprotein (cruzin) to Trypanosoma cruzi Mol Biochem Parasitol 28: 257–264PubMedCrossRefGoogle Scholar
  48. Requena JM, Lopez MC, Himenez-Ruiz A, de la Torre JC and Alonso C (1988) A head-to-tail tandem organisation of hsp 70 genes in Trypanosoma cruzi Nucleic Acids Res 16: 1393–1406PubMedCrossRefGoogle Scholar
  49. Ribiero dos Santos R and Hudson L (1980) Immunological consequences of parasite modification of host cells. Clin Exp Immunol 40: 36–41Google Scholar
  50. Ribiero dos Santos R, Marquez JO, Von Gal Furtado CC, Ramos de Oliveira JC, Martins AR and Koberle F (1979) Antibodies against neurons in chronic Chagas’ disease. Tropenmed Parasitol 30: 19–23Google Scholar
  51. Sacks DL, Kirchhoff LV, Hieny S and Sher A (1985) Molecular mimicry of a carbohydrate epitope on a major surface glycoprotein ofTrypanosoma cruzi by using anti-idiotype antibodies. J Immunol 135/7: 4155–4159PubMedGoogle Scholar
  52. Santos Buch CA (1979) American trypanosomiasis: Chagas’ disease. Int Rev Exp Pathol 19: 63–95Google Scholar
  53. Scharfstein J, Rodrigues MM, Alves CA, De Souza W, Previato JO and Mendonca-Previato L (1983) Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies. J Immunol 131: 972–976Google Scholar
  54. Schechter M and Nogueira N (1988) Variations induced by different methodologies in Trypanosoma cruzi surface antigen profiles. Mol Biochem Parasitol 29: 37–46PubMedCrossRefGoogle Scholar
  55. Scott MT and Snary D (1979) Protective immunisation of mice using cell surface glycoprotein from Trypanosoma cruzi Nature 282: 73–74PubMedCrossRefGoogle Scholar
  56. Sher A and Snary D (1982) Specific inhibition of the morphogenesis of Trypanosoma cruzi by a monoclonal antibody. Nature 300: 639–640PubMedCrossRefGoogle Scholar
  57. Snary D (1980) Trypanosoma cruzi: antigenic in variance of the cell surface glycoprotein. Exp Parasitol 49:68–77PubMedCrossRefGoogle Scholar
  58. Snary D (1983) Cell surface glycoproteins of Trypanosoma cruzi: protective immunity in mice and antibody levels in human chagasic sera. Trans R Soc Med Hyg 77: 126–129CrossRefGoogle Scholar
  59. Snary D (1985) The cell surface of Trypanosoma cruzi Curr Top in Microbiol Immunol 117: 75–92CrossRefGoogle Scholar
  60. Snary D and Hudson L (1979) Trypanosoma cruzi cell surface proteins: identification of one major glycoprotein. FEBS Lett 100: 166–170PubMedCrossRefGoogle Scholar
  61. Snary D, Ferguson MA J, Scott MT and Allen AK (1981) Cell surface antigens of Trypanosoma cruzi: use of monoclonal antibodies to identify and isolate an epimastigote specific glycoprotein. Mol Biochem Parasitol 3: 343–356PubMedCrossRefGoogle Scholar
  62. Snary D, Flint JE, Wood NJ, Scott MT, Chapman MD, Dodd J, Jessell TM and Miles MA (1983) A monoclonal antibody with specificity for Trypanosoma cruzi: central and peripheral neurons and glia. Clin Exp Immunol 54: 617–624PubMedGoogle Scholar
  63. Sterin-Bordu L, Cossio PM, Gimeno MF, Gimeno AL, Diez C, Laguens RP, Meckert PC, Arana RM (1976) Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and functional aspects. Cardiovasc Res 10: 613–622CrossRefGoogle Scholar
  64. Szarfman A, Luguettia A, Rossi A, Rezende JM and Schmunis GA (1981) Tissue reacting immunoglobulins in patients with different clinical forms of Chagas’ disease. Am J Trop Med Hyg 30: 43PubMedGoogle Scholar
  65. Szarfman A, Terranova VP, Rennard SI, Foidart JM, Lima MDF, Scheinman JI and Martin GR (1982) Antibodies to laminin in Chagas’ disease. J Exp Med 155: 1161–1171PubMedCrossRefGoogle Scholar
  66. Tamkun JW, De Simone DW, Fonda D, Patel RS, Buck C, Horwitz AF and Hynes RO (1986) Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46: 271–282PubMedCrossRefGoogle Scholar
  67. Teixeira ARL (1979) Chagas’ disease: trends in immunological research and prospects for immunoprophylaxis. Bull WHO 57: 697–714PubMedGoogle Scholar
  68. Towbin H, Rosenfielder G, Wieslander J, Avila JL, Rojas M, Szarfman A, Esser K, Nowack H and Timpl R (1987) Circulating antibodies to mouse laminin in Chagas’ disease, American cutaneous leishmaniasis and normal individuals recognise terminal galactosyl a(l-3)-galactose epitopes. J Exp Med 166: 419–432PubMedCrossRefGoogle Scholar
  69. Vianna G (1911) Contribuicoes para o estudo de anatomia patalogiacada molestia de Carlos Chagas. Mem Inst Oswaldo Cruz 3: 276–294CrossRefGoogle Scholar
  70. WHO (1960) Chagas’ disease report of a study group. WHO tech rep ser no 20Google Scholar
  71. Williams GT, Fielder L, Smith H and Hudson L (1985) Adsorption of Trypanosoma cruzi proteins to mammalian cells in vitro. Acta Tropica 42: 33–38PubMedGoogle Scholar
  72. Wood JN, Hudson L, Jessell TM and Yamamoto M (1982) A monoclonal antibody defining determinants on sub populations of mammalian neurones and Trypanosoma cruzi parasites. Nature 296:34–38PubMedCrossRefGoogle Scholar
  73. Wrightsman RA, Leon W and Manning JE (1986) Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi Infect Immun 53: 235–239PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • G. B. Takle
    • 1
  • L. Hudson
    • 1
  1. 1.Department of ImmunologySt. George’s Hospital Medical SchoolCranmer Terrace, LondonUK

Personalised recommendations